Eagle Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,001,572
| Closed | -$22.1M | – | 641 |
|
|
2016
Q2 | $22.1M | Buy |
1,001,572
+7,747
| +0.8% | +$171K | 0.15% | 192 |
|
|
2016
Q1 | $29.2M | Sell |
993,825
-102,239
| -9% | -$3M | 0.2% | 155 |
|
|
2015
Q4 | $36.2M | Buy |
1,096,064
+41,619
| +4% | +$1.37M | 0.24% | 145 |
|
|
2015
Q3 | $38.1M | Sell |
1,054,445
-293,383
| -22% | -$10.6M | 0.26% | 130 |
|
|
2015
Q2 | $60.6M | Buy |
1,347,828
+220,590
| +20% | +$9.92M | 0.34% | 106 |
|
|
2015
Q1 | $34.5M | Buy |
1,127,238
+17,594
| +2% | +$539K | 0.2% | 166 |
|
|
2014
Q4 | $56.4M | Buy |
1,109,644
+183,771
| +20% | +$9.34M | 0.32% | 108 |
|
|
2014
Q3 | $36.6M | Buy |
925,873
+123,514
| +15% | +$4.89M | 0.21% | 160 |
|
|
2014
Q2 | $34.6M | Buy |
802,359
+273,016
| +52% | +$11.8M | 0.19% | 170 |
|
|
2014
Q1 | $21.2M | Buy |
+529,343
| New | +$21.2M | 0.12% | 238 |
|